Customer Base

Alfa Wassermann Separation Technologies is the leading supplier of separation and purification systems to the world’s vaccine industry. Around 90% of the influenza vaccine manufacturers in the western world use KII and/or PKII continuous flow ultracentrifuges for production.

AWST also helps research centers in the research and development of bioactive molecules.

Full support is provided for contract manufacturers who provide additional capacity for the pharmaceutical industry.

With the development of its aseptic models, AWST is now extending its area of applications to viral vectors, the field that is expected to provide many of the future vaccines for diseases such as AIDS.

The choice of instruments from AWST is based upon several benefits:

• High levels of reliability (machines over 30 years old still in use)

• Flexible scale-up (with no revalidation of the protocol required)

• Clarification, concentration and purification in a single step

• Negligible consumables to dispose of.

• High infectivity levels maintained (No loss due to shear forces)

• High yields

Adeno Associated Virus

Hepatitis B Virus